DMH-25

• Description :

  DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  489.94

• Molecular Formula :

  C15H8Br3NO3

• Notes :

  Research use only, not for human use.

• Receptor :

  MTOR

• CAS Number :

  1685280-21-0